Company Information

KDL BIOTECH LTD.

NSE : NABSE : 532291ISIN CODE : INE746A01010Industry : Pharmaceuticals & DrugsHouse : Parijat
BSE2.140 (0 %)
PREV CLOSE ( ) 2.14
OPEN PRICE ( ) 2.14
BID PRICE (QTY) 2.14 (584)
OFFER PRICE (QTY) 2.36 (1)
VOLUME 4811
TODAY'S LOW / HIGH ( )2.14 2.14
52 WK LOW / HIGH ( ) 2.142.14
NSE
This Company is not listed in NSE
Managing DirectorNalin Bamzai
Additional DirectorAvantika Varma
Executive Director - TechnicalRajesh Agrawal
Non Executive & Independent DirectorSanjay Sinha
Incorporation Year : 1986

Registered Office :

Address : Village Savroli,Taluka Khalapur,Raigad Dist Savroli,
Maharashtra-410202 .

Phone : 02192- 274025 / 26/ 27/ 28/ 29/ 30

Email :  -- 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.